Quotient Stock Price

0.0023 (1.3%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,275,765
Bid Price 0.141
Ask Price 0.2001
News -
Day High 0.18


52 Week Range


Day Low 0.1674
Company Name Stock Ticker Symbol Market Type
Quotient Ltd QTNT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0023 1.3% 0.1798 00:00:06
Open Price Low Price High Price Close Price Prev Close
0.1771 0.1674 0.18 0.1733 0.1775
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,511 1,275,765 $ 0.1730448 $ 220,764 - 0.16 - 3.185
Last Trade Time Type Quantity Stock Price Currency
19:38:33 50 $ 0.1709 USD


Draw Mode:

Quotient Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.42M 135.80M 68.70M $ 38.51M $ - -1.24 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 9.57M 2.20%

more financials information »

Quotient News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QTNT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.23480.2430.16740.20191373,392,834-0.055-23.42%
1 Month0.21820.2430.160.19329433,761,769-0.0384-17.6%
3 Months0.2430.31650.160.23259443,487,679-0.0632-26.01%
6 Months1.071.310.160.2897012,298,408-0.8902-83.2%
1 Year2.663.1850.160.73217421,539,080-2.48-93.24%
3 Years8.5410.500.163.18969,171-8.36-97.89%
5 Years4.5711.300.163.95730,492-4.39-96.07%

Quotient Description

Quotient Ltd is a commercial-stage diagnostics company. It is involved in the development, manufacturing, and commercialization of conventional reagent products used for blood grouping within the global transfusion diagnostics market. The company develops and commercializes the Mosaiq automation platform. Its product portfolio includes Reagent Red Blood Cells, Antisera Products, Whole Blood Controls, and Ancillary Products. The firm operates in Edinburgh, Scotland, Eysins, Switzerland, and Newton, Pennsylvania. It derives the majority of its revenue from the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now